Response to Merck's Ebola vaccine lasts at least a year, study finds

13th June 2017 Uncategorised 0

In a phase 3 trial in West Africa, Merck’s Ebola vaccine showed it can elicit a quick immune response. Now, a new study in the U.S. found that the vaccine’s protective qualities can last for at least a year.

More: Response to Merck's Ebola vaccine lasts at least a year, study finds
Source: fierce